BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37737848)

  • 1. Clinicopathological features and prognosis of synchronous and metachronous colorectal cancer: a retrospective cohort study.
    Fan H; Wen R; Zhou L; Gao X; Lou Z; Hao L; Meng R; Gong H; Yu G; Zhang W
    Int J Surg; 2023 Dec; 109(12):4073-4090. PubMed ID: 37737848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
    Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
    Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
    Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
    Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
    Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
    Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
    Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
    Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
    JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
    Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
    Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
    Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
    Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.
    Yoon SN; Oh ST; Lim SB; Kim TW; Kim JH; Yu CS; Kim JC
    World J Surg; 2010 Sep; 34(9):2168-76. PubMed ID: 20532772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of multiple sporadic colorectal carcinoma.
    Cecchini S; Azzoni C; Bottarelli L; Marchesi F; Rubichi F; Silini EM; Roncoroni L
    Acta Biomed; 2017 Apr; 88(1):39-44. PubMed ID: 28467332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of synchronous and metachronous duodenal tumors and association with colorectal cancer: a supplementary analysis.
    Yamasaki Y; Kato M; Takeuchi Y; Hoteya S; Oyama T; Nonaka S; Yoshimizu S; Yoshida M; Ohata K; Miura Y; Hara Y; Tsuji S; Dohi O; Ueyama H; Kurahara K; Tashima T; Abe N; Mitsuhashi T; Nakayama A; Oda I; Yahagi N
    J Gastroenterol; 2023 May; 58(5):459-469. PubMed ID: 36847918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease.
    Tan EK; Ooi LL
    Ann Acad Med Singap; 2010 Sep; 39(9):719-15. PubMed ID: 20957308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
    Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
    BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.